Michael G. Davis

Michael G. Davis serves as a key procurement professional at the Naval Medical Center Portsmouth, supporting the Department of the Navy’s mission to sustain operational medical readiness through the acquisition of high-precision surgical and electromedical equipment. He manages the full lifecycle of contracts for specialized medical instruments, diagnostic devices, and laboratory systems critical to trauma care, surgical suites, and clinical diagnostics. His work directly enables the center’s ability to deliver advanced, life-saving care to active-duty personnel, veterans, and their families, ensuring compliance with military medical standards and readiness requirements. Davis maintains strategic relationships with a network of manufacturers and suppliers specializing in surgical instrument fabrication and electromedical technology. While no single contractor dominates his portfolio, he consistently engages with firms possessing FDA-clearance, ISO 13485 certification, and military-specification compliance. His contracting approach emphasizes technical validation, quality assurance protocols, and supply chain resilience, fostering long-term vendor partnerships that meet the rigorous demands of naval medical operations. A strong advocate for small business participation, Davis prioritizes Total Small Business Set-Asides under FAR 19.5, allocating 40% of his acquisitions to small businesses. This reflects a deliberate commitment to expanding market access for capable vendors without socioeconomic designations, while still ensuring competitive, high-quality sourcing. His contracting patterns demonstrate balanced support for small business innovation alongside broad-based competition. His procurement focus is exclusively concentrated in NAICS 339112—Surgical and Medical Instrument Manufacturing—reflecting deep expertise in procuring custom-fabricated surgical tools, laparoscopic systems, electrosurgical units, and laboratory analyzers. He possesses specialized knowledge of medical device classifications, sterilization requirements, and FDA regulatory pathways, ensuring all acquisitions align with clinical safety standards and DoD logistical frameworks.